Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Shares Issued (2016 - 2025)

Regenxbio has reported Shares Issued over the past 11 years, most recently at -$748000.0 for Q4 2025.

  • Quarterly results put Shares Issued at -$748000.0 for Q4 2025, down 342.07% from a year ago — trailing twelve months through Dec 2025 was $300000.0 (down 80.0% YoY), and the annual figure for FY2025 was $300000.0, down 80.0%.
  • Shares Issued for Q4 2025 was -$748000.0 at Regenxbio, down from $820000.0 in the prior quarter.
  • Over the last five years, Shares Issued for RGNX hit a ceiling of $3.7 million in Q3 2023 and a floor of -$3.4 million in Q4 2023.
  • Median Shares Issued over the past 5 years was $471000.0 (2023), compared with a mean of $492789.5.
  • Biggest five-year swings in Shares Issued: skyrocketed 3682.35% in 2023 and later tumbled 342.07% in 2025.
  • Regenxbio's Shares Issued stood at $2.5 million in 2021, then crashed by 104.03% to -$102000.0 in 2022, then plummeted by 3187.25% to -$3.4 million in 2023, then surged by 109.22% to $309000.0 in 2024, then tumbled by 342.07% to -$748000.0 in 2025.
  • The last three reported values for Shares Issued were -$748000.0 (Q4 2025), $820000.0 (Q3 2025), and -$79000.0 (Q2 2025) per Business Quant data.